Resources
How integrated care systems can improve diabetic macular oedema care
Outputs of World Cafe Event
In December 2022, Bayer convened stakeholders from the eye care community to discuss practical steps to improve diabetic macular oedema (DMO) services. The aim was to gather insights and align on potential solutions that could be replicated across the NHS.
Practical Steps to improve DMO services:
Outputs of World Cafe Event
Bayer is committed to supporting healthcare institutions nationwide, recognising their uniqueness. By collaborating with centres and stakeholders across the UK, we can enhance understanding, identify areas for improvement, and assist in creating bespoke action plans based on your service model and available resources.
Prescribing information for EYLEA® (aflibercept) can be found here
PP-MACS-GB-0312 | October 2024